comparemela.com

Latest Breaking News On - Eisai - Page 5 : comparemela.com

Eisai (OTCMKTS:ESALY) Trading Down 2.1%

Eisai Co., Ltd. (OTCMKTS:ESALY – Get Free Report)’s share price dropped 2.1% during trading on Monday . The company traded as low as $61.00 and last traded at $61.51. Approximately 331,800 shares were traded during trading, an increase of 445% from the average daily volume of 60,916 shares. The stock had previously closed at $62.84. […]

Japan
Eisai-co-ltd
Get-free-report
Pharmaceutical-products-business
Eisai-daily
Eisai
Otcmkts-esaly
Esaly
Medical
Stocks
Technicals

TOKYO Japanese drugmaker Eisai will apply for regulatory approval in the U.S. for preventative use of Alzheimer's drug, lecanemab as soon as the fi

Japan
Japanese
Eisai
Seeks
Expanded
Use
Alzheimer-s
Drug
Prevention

Biogen cuts annual profit forecast on Alzheimer's drug launch, deal costs

Biogen said it now expects full-year adjusted profit of $14.50 to $15.00 per share, the new high end of the range matching the low end of its previous forecast of $15 to $16

Japan
Japanese
Christopher-viehbacher
Evan-seigerman
William-blair
Myles-minter
Reata-pharmaceuticals
Log-increate-free
Wall-street
Biogen
Share
End

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.